Laura Chico

Stock Analyst at Wedbush

(4.05)
# 580
Out of 4,650 analysts
199
Total ratings
48.12%
Success rate
12.33%
Average return

Stocks Rated by Laura Chico

Alto Neuroscience
Oct 23, 2024
Downgrades: Neutral
Price Target: $29$4
Current: $4.01
Upside: -0.25%
Sage Therapeutics
Oct 9, 2024
Maintains: Neutral
Price Target: $9$8
Current: $8.48
Upside: -5.66%
Travere Therapeutics
Oct 9, 2024
Maintains: Outperform
Price Target: $17$25
Current: $18.37
Upside: +36.09%
Larimar Therapeutics
Oct 3, 2024
Initiates: Outperform
Price Target: $22
Current: $7.78
Upside: +182.78%
Biogen
Sep 23, 2024
Maintains: Neutral
Price Target: $210$205
Current: $183.47
Upside: +11.73%
Longboard Pharmaceuticals
Sep 17, 2024
Maintains: Outperform
Price Target: $40$44
Current: $59.57
Upside: -26.14%
Edgewise Therapeutics
Aug 16, 2024
Reiterates: Outperform
Price Target: $31
Current: $34.45
Upside: -10.01%
Praxis Precision Medicines
Aug 14, 2024
Maintains: Neutral
Price Target: $40$48
Current: $71.03
Upside: -32.42%
Astria Therapeutics
Aug 13, 2024
Reiterates: Outperform
Price Target: $22
Current: $11.99
Upside: +83.49%
Gossamer Bio
Aug 13, 2024
Reiterates: Outperform
Price Target: $4
Current: $0.91
Upside: +337.49%
Maintains: Neutral
Price Target: $38$41
Current: $27.41
Upside: +49.58%
Maintains: Outperform
Price Target: $50$49
Current: $41.78
Upside: +17.28%
Maintains: Outperform
Price Target: $38$36
Current: $27.75
Upside: +29.73%
Maintains: Neutral
Price Target: $8$7
Current: $7.07
Upside: -0.99%
Maintains: Outperform
Price Target: $30$26
Current: $27.47
Upside: -5.35%
Maintains: Neutral
Price Target: $43$46
Current: $52.80
Upside: -12.88%
Reiterates: Outperform
Price Target: $11
Current: $6.01
Upside: +83.03%
Reiterates: Outperform
Price Target: $20
Current: $7.28
Upside: +174.73%
Reiterates: Outperform
Price Target: $42
Current: $22.74
Upside: +84.70%
Reiterates: Outperform
Price Target: $23
Current: $3.82
Upside: +502.09%
Reiterates: Outperform
Price Target: $17
Current: $12.40
Upside: +37.10%
Reiterates: Outperform
Price Target: $41
Current: $2.26
Upside: +1,714.16%
Reiterates: Outperform
Price Target: $152
Current: $116.19
Upside: +30.82%
Maintains: Outperform
Price Target: $35$31
Current: $23.75
Upside: +30.53%
Maintains: Outperform
Price Target: $13$11
Current: $1.02
Upside: +978.43%
Initiates: Outperform
Price Target: $8
Current: $1.19
Upside: +572.27%
Maintains: Neutral
Price Target: $21$34
Current: $42.97
Upside: -20.88%
Reiterates: Neutral
Price Target: $5
Current: $5.41
Upside: -7.58%
Initiates: Market Perform
Price Target: n/a
Current: $69.91
Upside: -
Maintains: Outperform
Price Target: $9$5
Current: $1.88
Upside: +165.96%
Downgrades: Neutral
Price Target: $149
Current: $50.95
Upside: +191.46%
Initiates: Outperform
Price Target: $720
Current: $16.20
Upside: +4,344.44%
Initiates: Strong Buy
Price Target: $280
Current: $13.39
Upside: +1,991.11%